Resources:
On 25 June 2024, RWE4Decisions hosted a webinar titled “Can endpoints from digital technology provide meaningful outcomes for Health Technology Assessment (HTA)?”
At the webinar, speakers discussed how patient-generated health data could be analyzed to support Health Technology Assessment (HTA) bodies and Payers, delving into issues such as app governance models, the use of AI, and more.
Senior Health Economist, OECD
RWE4Decisions Secretariat
Head of the HTA for AI Unit, ALTEMS Università Cattolica; Co-Chair HTAi HB-HTA Interest Group
Board Member, Cystic Fibrosis Europe
Senior Advisor, Methodologist in Regulatory and Pharmacoeconomic Statistics, Norwegian Medicinal Products Agency (NOMA)
Associate Vice-President & Head HTA Statistics, MSD; Co-Chair, PSI/EFPSI HTA Special Interest Group
Public Webinar: From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
Public Webinar: HTA/Payer Collaboration in the Nordics: The Role of Real-World Evidence
